The purpose for this study was to examine the efficacy of patient-controlled sedation (PCS) with remifentanil as an intravenous adjunct to local anaesthesia for treating pain associated with dental extraction during monitored anaesthetic care. Forty ASA 1-2 and aged 18 or older Chinese patients presenting for third molar extraction on an outpatient basis were randomly assigned to either remifentanil (RG; n=20) or saline groups (CG; n=20). All patients completed the study. Patients in the RG and CG were comparable in terms of demographic variables, PCS demands and PCS boluses. There was high variability of PCS among patients in both groups in terms of demands (range for RG 0-62; CG 0-41) and consumption (range for RG 0-26; CG 0-13). Neither group required any rescue local anaesthetic injection for pain or midazolam for anxiety. There was no clinically relevant differences in outcome measures (pain scores, anxiety scores, systolic and diastolic blood pressures, heart rate, and SpO 2 ) between the two groups. There were no other major complications such as apnoea, desaturation, bradycardia, or chest wall rigidity in either group. We conclude that, although it appeared to be safe, the addition of patient-controlled remifentanil was not a useful adjunct to local anaesthesia for pain associated with third molar dental extraction.
Third molar extraction is a commonly performed procedure in the ambulatory setting. In order to manage intraoperative pain and anxiety associated with the surgical removal of third molar teeth, various techniques have been used. These include local anaesthesia in conjunction with both intravenous sedation and general anaesthesia. However, some patients who undergo dental extraction might not be suitable for, or prefer not to have, heavy sedation or general anaesthesia. Under these circumstances, conscious sedation might be a feasible option. However, conscious sedation could be difficult to provide because of the pharmacokinetic and pharmacodynamic variability of the sedative drugs, different interpatient requirements, and changing intraoperative conditions. Conscious sedation by propofol or midazolam with or without analgesic supplementation with opioids has been used in third molar surgery in various previous studies [1] [2] [3] [4] [5] [6] [7] .
It has been shown previously that patientcontrolled sedation (PCS) is superior to continuous infusion because it reduces the overall drug consumption while providing adequate sedation for patient requirements 8 . PCS also enabled patients to vary the degree of sedation according to the amount of stress caused by the procedure and the environment. Moreover, it had a placebo effect that allowed patients to have a greater sense of control and was associated with greater patient satisfaction 8 .
In this study, we used remifentanil, which is a piperidine derivative. It contains an ester linkage that makes it susceptible to metabolism by nonspecific esterases in blood and other tissues. It has a rapid onset of action. The time to peak drug effect after a bolus is 1.5 minutes. Its small volume of distribution, rapid redistribution, and clearance accounted for by rapid metabolism by ester hydrolysis, contribute to a terminal elimination half-life of 8.8-40 minutes 9 . Remifentanil is a typical µ-opioid receptor agonist with pharmacodynamic properties similar to that of fentanyl and its derivatives. It has been used extensively as an infusion for conscious sedation in third molar surgery and other procedures [10] [11] [12] [13] [14] [15] [16] .
Continuous remifentanil at an infusion rate of 0.05 µg/kg/min was shown to result in significantly lower peak heart rate and peak systolic blood pressure than meperidine 50 mg bolus intravenously during conscious sedation in outpatient oral surgery 17 . PCS bolus of remifentanil 25 µg with lockout time of 5 minutes plus a background infusion of 5 µg/kg/h was used effectively for gastrointestinal endoscopic procedures 18 . A PCS mode of drug administration has also been used for labour analgesia where epidural analgesia was contraindicated [19] [20] [21] [22] .
The main purpose of this study was to examine the efficacy of patient-controlled remifentanil as an intravenous adjunct to local analgesia for treating pain associated with dental extraction during monitored anaesthetic care. A secondary objective was to evaluate the safety of patient-controlled sedation of remifentanil.
METHODS
After obtaining approval from our Hospital Ethics Committee, 40 Chinese patients presenting for third molar extraction on an outpatient basis were enrolled. All patients gave written consent and they were ASA 1 or 2 and aged 18 years or older with exclusion criteria as summarized in Figure 1 . Subjects were randomly assigned to either remifentanil (20 patients) or saline groups (20 patients). The patients, anaesthetists, investigator, and nursing staff were all blinded to the assigned treatment.
Patients were fasted for at least eight hours before surgery. No anaesthetic premedication was administered. The patients were taught how to use the patient controlled device, and were asked to rate the degree of anxiety and pain on a verbal score (VAS) of 0 (no pain/anxiety) to 10 (greatest pain/anxiety) before operation.
After arrival to the operating theatre, electrocardiogram, pulse oximeter, and non-invasive blood pressure cuff were placed. Readings (SpO 2 , respiratory rate, systolic and diastolic blood pressure, heart rate) were recorded at baseline, immediately after three boluses, and then every five minutes until the end of operation. All patients received supplementary O 2 2 l/min by nasal cannula throughout the operation. Intravenous access was established and 1l of normal saline was administered intravenously over one hour perioperatively.
The patient-controlled device (Graseby 3300, Graseby Medical Ltd, Hong Kong) was connected to a separate intravenous access to avoid accumulation of the study drug in the IV tubing. Patients were instructed to give themselves three doses of their PCS medication during the surgeon's draping before dental local infiltration was administered. The surgeon then injected local anaesthetic agent to the incision site. The concentration of dental local anaesthetic was standardized and consisted of 2% lignocaine with 1:80,000 adrenaline. After five minutes, the surgeon assessed the effect of local anaesthesia by placing a sharp explorer between the cuspid and first premolar. Additional local anaesthetic agent was administered as necessary. The surgical procedure was then allowed to proceed. After starting the operation, the patients were reminded to press the button when they felt discomfort or when pain relief was required.
Remifentanil was reconstituted to a concentration of 15 µg/ml (for patients with body weight <60 kg) or 20 µg/ml (for patients with body weight >60 kg). The device was set to deliver a bolus of 1 ml with zero lockout time (one millilitre of solution was delivered over 30 seconds via the Graseby pump, making effective lockout time of 30 seconds), and no dose limit over time. No background infusion was used.
The patients were asked to squeeze the hand of the anaesthetist at frequent intervals to ensure that consciousness was not lost. An apnoea episode was defined as absence of spontaneous breathing for more than 20 seconds. A desaturation episode was defined as SpO 2 less than 90% for more than five seconds. Patients were encouraged to take deep breaths if their SpO 2 fell to less than 90%.
Rescue therapy for pain was provided by administration of additional local infiltration by the surgeon when five demands were made within one minute or when patients complained of pain with scores of equal to or greater than 5. Rescue therapy for anxiety was provided by administration of midazolam 1 mg intravenously (up to a maximum dose of 4 mg) when five demands were made within one minute or when anxiety score was equal to or greater than 5. Metoclopramide 10 mg IV was prescribed as required if the patients had nausea or vomiting. Chlorpheniramine 10 mg IV was prescribed as required to treat 1. Known allergy to opioid analgesia. 2. Drug or substance abuse, or tendency of chronic narcotic use. 3. Anaesthesia or opioid use within 2 days before study participation. 4. Physical health status ASA 3 or above. 5. Significant psychiatric illness. 6. Mental retardation, or inability to understand or use patientcontrolled device. 7. Difficulty with communication. 8. Pregnant or breast-feeding patient. 9. If the expected degree of surgical difficulty is excessive for local analgesia and sedation. severe pruritus. At the end of the operation, PCS demands and boluses were recorded. Before the patients left the operating theatre, they were asked to rate the overall pain score and anxiety score for the whole duration of the intraoperative period. The patients were transferred to the day surgery recovery ward and regular observations were carried out according to day surgery recovery protocols. Sedation score was recorded once they arrived at the recovery ward. The level of sedation was assessed by using the scale: 1=fully awake and oriented, 2=drowsy, 3=eyes closed, responds promptly to verbal commands, 4=eyes closed, rousable on mild physical stimulation only, 5=eyes closed, unrousable on mild physical stimulation. Analgesic request, adverse effects, time to first sit out of bed, time to be ready for discharge were recorded. Before departure from the recovery ward, all patients were asked about the willingness to use the technique again if they were placed under similar circumstances, and overall satisfaction with the anaesthetic technique.
The sample size of 40 was calculated so as to ensure 80% power to detect a difference of 1.5 points on an 11 point verbal score for pain with a type 1 error probability of 0.05. The demographic data, operative variables, pain scores, anxiety scores, time to ready for discharge and actual discharge time between the two groups were analyzed by using independent t-tests.
RESULTS
All patients completed the study. Patients' demographic and surgical data were similar in both groups and are displayed in Table 1 . Mean PCS demand and PCS administered were similar but there was high variability among patients in both groups in terms of demands (range for RG 0-62; CG 0-41) and consumptions (range for RG 0-26; CG 0-13). Neither group required rescue local anaesthetic injection. No patient required midazolam for anxiety. None of the patients had apnoea or suffered from desaturation or bradycardia. There were no other major complications such as chest wall rigidity.
The pain scores and anxiety scores before and during operation were displayed in Table 2 . The pain scores were similar for RG and CG both before and during operation. Although there was a significant difference in the anxiety scores between the two groups, both before operation and during operation, the percentage increase in anxiety score during operation when compared with that before operation was similar for both groups.
The vital sign parameters (SBP, DBP, HR, SpO 2 , and RR) during the intraoperative period were similar in both groups except that patients in the RG had significantly lower respiratory rate at the time local anaesthetic was injected by the dental surgeons (P=0.03). All patients had SpO 2 of above 98% intraoperatively.
No patient requested analgesia in the recovery ward. All subjects had sedation scores of 1 (i.e. fully awake and oriented). The side-effects of both groups were shown in Table 3 . All patients in both groups gave satisfaction scores of good or above. They were satisfied with the patient-controlled technique, and were willing to use the same technique again if they were to come back for similar operation.
DISCUSSION
Apart from a significant decrease in respiratory rate in the RG (P=0.013) at the time of local anaesthetic injection, there was no clinically relevant difference in terms of outcome measures (pain scores, anxiety scores, systolic and diastolic blood pressure, heart rate, and SpO 2 ) between the two groups. Based on the main outcome measures of pain scores, we concluded that, although safe, patient-controlled remifentanil was not a useful intravenous adjunct 75 analgesia to local anaesthesia for treating pain and discomfort associated with dental extraction. Our sample size calculation was based on the assumption that the pain scores difference of the two groups was 1.5 points or more. If the actual difference in pain scores was less than 1.5 points, a statistically significant difference would not be detected with our small sample size and a larger study would be required to avoid a type 2 error.
REMIFENTANIL PCS
Another possible reason for the negative findings was that the dose of remifentanil used in the remifentanil group might be too low to allow a statistically significant reduction of pain scores to be shown. We chose a bolus dose of 15 µg (for patients with body weight <60 kg) or 20 µg (body weight 60 kg) as a previous dose-finding study indicated that the median effective PCA bolus was 0.4 µg/kg in obstetric analgesia 23 . The patient population in our study were all of Chinese origin who were generally lower in body weight and more sensitive to opioid than Caucasians and therefore we limited the PCS bolus to either 15 µg or 20 µg 24 . Our concern about using a larger dose was the increased incidence of side-effects. Before placement of regional ophthalmological blocks, when remifentanil was administered as a 1 µg/kg bolus, it was shown that the analgesic effect was accompanied by a brief period of slow breathing in 4 of 26 patients. In the dose finding study in which bolus dose of 20 µg delivered over one minute with three-minute lockout protocol was used, frequent desaturation episodes were noted 23 . The previously mentioned dose finding study using doses of remifentanil <2 µg/kg given over 1 minute was shown not to cause muscle rigidity 23 . Likewise, remifentanil used in patient-controlled analgesia for labour was not associated with muscle rigidity or serious respiratory de-pression when bolus doses of 20-75 µg with lockout time 2-3 minutes were used [19] [20] [21] [22] . We used a bolus dose of 15 µg or 20 µg of remifentanil with no lockout period (effective lockout period of 30 seconds) and no apnoea or desaturation episode was observed in our study. A lockout period of more than three minutes with individualized dosing of remifentanil might be more appropriate. However, this long lockout time might sacrifice the beneficial effect of allowing the patients to rapidly titrate the amount of their medications to the level of their own satisfaction.
A third possible reason for our negative finding is that the local anaesthetic agent administered by the dental surgeon was adequate for the operation and no additional analgesic supplements were actually required. This proposition is supported by the low intraoperative pain scores in both normal saline group and remifentanil groups, there also being no significant difference in pain scores between the two groups (1.5 vs 1.6, P=0.83). However, patients in both groups made a significant number of PCS demands. The high PCS demands might reflect that patients used their pump for anxiety rather than analgesia. Interestingly, the number of PCS demands and boluses for both groups does not differ significantly. A possible explanation for the lack of difference between the groups is a placebo effect in the saline group. It has been shown in other studies that up to 37% of patients had more than 50% of maximum possible pain relief after taking placebo 25 . It is interesting to note that the intraoperative anxiety scores for the remifentanil group was significantly lower than the normal saline group (5.6 vs 6.2, P=0.02). However, when comparing the preoperative anxiety scores of the two groups, the remifentanil group was also significantly lower than the normal saline group (3.5 vs 4.1, P=0.02). If we took the percentage increase/ reduction in anxiety scores, we found that the difference in increase in anxiety scores between the two groups was comparable (63.8% vs 56.2%, P=0.87). Similar increases in anxiety scores in both remifentanil and saline groups indicated that the third molar extraction operation was a stressful procedure. Patients in both groups made similar PCS demands (9.1 vs 7.9, P=0.8) for relief of pain or anxiety. As the difference in anxiety scores in both groups was comparable, and the satisfaction scores in both groups were good or better, one could postulate that the PCS technique might be helpful through its placebo effect.
The variability of PCS demands among patients in both groups was high. There are many possible contributory factors. It might reflect differences in individual tolerance to pain and anxiety level. It might also reflect actual differences in pain or anxiety levels as there were differences in teeth position, surgical difficulty, duration of operation, and number of teeth extracted among patients in the same study group. Seven patients in the remifentanil group had minor side-effects that were all amenable to treatment. The slight increase in time to ready for discharge in the remifentanil group compared to the saline group (85 vs 69 minutes, P=0.06) might possibly be due to these side-effects. However, in real terms, these minor side-effects did not prolong the actual time to discharge (124 vs 115 minutes, P=0.43) which was more dependent on the administrative factors.
It is well known that verbal pain or anxiety scores are not precise measurement of the pain intensity suffered by the patients. In fact, two patients in this study had pain scores of one even before operation. The imprecise measurement of pain using verbal pain scores might be due to individual variation in pain perception, and different interpretation of pain scores. Unfortunately there was no suitable alternative. The use of visual analogue scales using a ruler was not practical during the operation when patients' eyes were covered up and fine hand movement was not allowed. Other outcome measures used in our study such as heart rate, blood pressure and respiratory rate, which were the physiological responses to pain and anxiety, might help to estimate the levels of pain or anxiety or combination of both.
Based on our results, we conclude that addition of patient-controlled remifentanil did not result in a reduction of pain scores and therefore it is not a useful intravenous adjunct analgesia to local anaesthesia for treating pain and discomfort associated with dental extraction. However we did find patientcontrolled remifentanil safe. Also the PCS technique itself, with either remifentanil or saline, did appear to help patients' anxiety and led to high patient satisfaction levels. We would suggest repeating the study in a group of patients having more painful procedures under local anaesthesia.
